Oncodea
Saint Paul, US · Founded 2021 · Delaware corporation · 1 known investors
Oncodea is a cancer research company developing early cancer detection and monitoring methods intended to be fast, affordable, and accessible to a broad population. It positions itself as more than a research lab, focused on making cancer testing inexpensive enough for regular use.
Founders & leadership
AK
Ali KhammanivongNamed on SEC filing
DQ
Dan Que PhamNamed on SEC filing
YY
Yung-Ping YehNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$275.8K disclosed across 1 round · 2022
▶$275.8KraisedApr 2022 · 4 investors · BiotechnologyRule 506(b)
▶$275.8KraisedApr 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ali KhammanivongDirector
- Dan Que PhamExecutive Officer, Director
- Yung-Ping YehDirector
- Offering amount
- $850K
- Amount sold
- $275.8K
- Minimum investment
- $25K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Oncodea for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Oncodea do?
- Oncodea is a cancer research company developing early cancer detection and monitoring methods intended to be fast, affordable, and accessible to a broad population. It positions itself as more than a research lab, focused on making cancer testing inexpensive enough for regular use.
- Who are Oncodea's investors?
- Oncodea's investors include GROOVE CAPITAL.
- How much funding has Oncodea raised?
- Oncodea has disclosed $275.8K raised across 1 round.
- Where is Oncodea headquartered?
- Oncodea is headquartered in Saint Paul, US.